European Commission (EC) has granted marketing authorization for Lorviqua as monotherapy for treatment of patients with anaplastic lymphoma kinase (ALK) – positive advanced non-small cell lung cancer. Lorviqua is approved in US…
Author: Lung Cancer
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The United States Preventive Services…
Sugemalimab with Chemo Demonstrates Improvement in NSCLC Survival Rates
In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading cause of cancer deaths….
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how…
Study Finds Blood Tests to help Predict Lung Cancer Screenings
According to a new study published in the Journal of Clinical Oncology, a blood test along with a risk model based on person’s history can more accurately find whether the person can…
Study: Lung Cancer Screenings Associated with Death Decline
Lung cancer is one of the leading causes of cancer deaths in the United States and is diagnosed in more than 2lac people annually. According to a Mount Sinai study published in…
Lymph Nodes – Common Site of Lung Cancer Spread
One of the biggest issues that are being faced by lung cancer patients is that the cancer may spread to other parts of the body. The term used when cancer spreads to…
A Drop of Blood Can Detect Early Stage Lung Cancer
As per the study conducted by Massachusetts General Hospital researchers, a predictive model can work to detect early-stage lung cancer from a drop of blood. Lung cancer remains the leading cause of…